OBJECTIVE: To describe red blood cell (RBC) transfusion practices and evaluate the association between patient-related factors and pretransfusion hemoglobin concentration in acute lung injury (ALI). DESIGN: Secondary analysis of prospectively collected data. SETTING: Nine intensive care units (ICUs) in three teaching hospitals in Baltimore, MD. PATIENTS: Two hundred forty-nine consecutive patients with ALI requiring mechanical ventilation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Simple and multiple linear regression analyses were used to evaluate the association between the nadir hemoglobin concentration on the day of initial RBC transfusion and 20 patient-level demographic, clinical and ICU treatment factors as well as ICU type. Of 249 patients with ALI, 47% received an RBC transfusion in the ICU without evidence of active hemorrhage or acute cardiac ischemia. The mean (sd) nadir hemoglobin on the day of first transfusion was 7.7 (1.1) g/dL with 67%, 36%, 15%, and 5% of patients transfused at >7, >8, >9, and >10 g/dL, respectively. Transfused patients received a mean (sd) of 5 (6) RBC units from ALI diagnosis to ICU discharge. Prehospital use of iron or erythropoietin and platelet transfusion in the ICU were independently associated with lower pretransfusion hemoglobin concentrations. No patient factors were associated with higher hemoglobin concentrations. Admission to a surgical (vs. medical) ICU was independently associated with a 0.6 g/dL (95% confidence interval 0.1-1.1 g/dL) higher pretransfusion hemoglobin. CONCLUSIONS: Patients with ALI commonly receive RBC transfusions in the ICU. The pretransfusion hemoglobin observed in our study was lower than earlier studies, but a restrictive strategy was not universally adopted. Patient factors do not explain the gap between clinical trial evidence and routine transfusion practices. Future studies should further explore ICU- and physician-related factors as a source of variability in transfusion practice.
OBJECTIVE: To describe red blood cell (RBC) transfusion practices and evaluate the association between patient-related factors and pretransfusion hemoglobin concentration in acute lung injury (ALI). DESIGN: Secondary analysis of prospectively collected data. SETTING: Nine intensive care units (ICUs) in three teaching hospitals in Baltimore, MD. PATIENTS: Two hundred forty-nine consecutive patients with ALI requiring mechanical ventilation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Simple and multiple linear regression analyses were used to evaluate the association between the nadir hemoglobin concentration on the day of initial RBC transfusion and 20 patient-level demographic, clinical and ICU treatment factors as well as ICU type. Of 249 patients with ALI, 47% received an RBC transfusion in the ICU without evidence of active hemorrhage or acute cardiac ischemia. The mean (sd) nadir hemoglobin on the day of first transfusion was 7.7 (1.1) g/dL with 67%, 36%, 15%, and 5% of patients transfused at >7, >8, >9, and >10 g/dL, respectively. Transfused patients received a mean (sd) of 5 (6) RBC units from ALI diagnosis to ICU discharge. Prehospital use of iron or erythropoietin and platelet transfusion in the ICU were independently associated with lower pretransfusion hemoglobin concentrations. No patient factors were associated with higher hemoglobin concentrations. Admission to a surgical (vs. medical) ICU was independently associated with a 0.6 g/dL (95% confidence interval 0.1-1.1 g/dL) higher pretransfusion hemoglobin. CONCLUSIONS:Patients with ALI commonly receive RBC transfusions in the ICU. The pretransfusion hemoglobin observed in our study was lower than earlier studies, but a restrictive strategy was not universally adopted. Patient factors do not explain the gap between clinical trial evidence and routine transfusion practices. Future studies should further explore ICU- and physician-related factors as a source of variability in transfusion practice.
Authors: M P Rao; Harsha Boralessa; C Morgan; N Soni; D R Goldhill; S J Brett; Hari Boralessa; M Contreras Journal: Anaesthesia Date: 2002-06 Impact factor: 6.955
Authors: Craig J French; Rinaldo Bellomo; Simon R Finfer; Jeffery Lipman; Marianne Chapman; Neil W Boyce Journal: Med J Aust Date: 2002-11-18 Impact factor: 7.738
Authors: Giora Netzer; Chirag V Shah; Theodore J Iwashyna; Paul N Lanken; Barbara Finkel; Barry Fuchs; Wensheng Guo; Jason D Christie Journal: Chest Date: 2007-05-15 Impact factor: 9.410
Authors: Jean Louis Vincent; Jean-François Baron; Konrad Reinhart; Luciano Gattinoni; Lambert Thijs; Andrew Webb; Andreas Meier-Hellmann; Guy Nollet; Daliana Peres-Bota Journal: JAMA Date: 2002-09-25 Impact factor: 56.272
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Robert W Taylor; Lisa Manganaro; Jacklyn O'Brien; Steven J Trottier; Nadeem Parkar; Christopher Veremakis Journal: Crit Care Med Date: 2002-10 Impact factor: 7.598
Authors: Marya D Zilberberg; Chureen Carter; Patrick Lefebvre; Monika Raut; Francis Vekeman; Mei Sheng Duh; Andrew F Shorr Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: David J Murphy; Peter J Pronovost; Christoph U Lehmann; Ayse P Gurses; Glenn J R Whitman; Dale M Needham; Sean M Berenholtz Journal: Transfusion Date: 2014-05-21 Impact factor: 3.157
Authors: Giora Netzer; Xinggang Liu; Anthony D Harris; Bennett B Edelman; John R Hess; Carl Shanholtz; David J Murphy; Michael L Terrin Journal: Transfusion Date: 2010-10 Impact factor: 3.157
Authors: Michael D Dallman; Xinggang Liu; Anthony D Harris; John R Hess; Bennett B Edelman; David J Murphy; Giora Netzer Journal: Pediatr Crit Care Med Date: 2013-11 Impact factor: 3.624